Unknown

Dataset Information

0

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.

ABSTRACT:

SUBMITTER: Schuit E 

PROVIDER: S-EPMC6483659 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
| S-EPMC6698953 | biostudies-literature
Unknown Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
| S-EPMC3946972 | biostudies-literature
Unknown Biomarkers for smoking cessation.
| S-EPMC3772534 | biostudies-literature
Unknown Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.
| S-EPMC4014023 | biostudies-literature
Unknown Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
| S-EPMC7183430 | biostudies-literature
Unknown Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy.
| S-EPMC3265742 | biostudies-literature
Unknown Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.
| S-EPMC5939704 | biostudies-literature
Unknown Nicotine Metabolism-informed Care for Smoking Cessation: A Pilot Precision RCT.
| S-EPMC6236077 | biostudies-literature
Unknown A systematic approach to subgroup analyses in a smoking cessation trial.
| S-EPMC4817346 | biostudies-literature
Unknown Prevalence and correlates of smoking cessation pharmacotherapy in hospitalized smokers with acute myocardial infarction.
| S-EPMC3269665 | biostudies-other